Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience için istatistikler
Toplam ziyaret
views | |
---|---|
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ekim 2024 | 0 |
Kasım 2024 | 0 |
Aralık 2024 | 0 |
Ocak 2025 | 0 |
Şubat 2025 | 0 |
Mart 2025 | 0 |
Nisan 2025 | 0 |